Boston Private Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Boston Private Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$189K	Hold	1,088	–	–	0.01%	401
2014 Q4	$201K	Buy	1,088 +188	+21%	+$34.8K	0.01%	397
2014 Q3	$149K	Hold	900	–	–	0.01%	430
2014 Q2	$141K	Hold	900	–	–	0.01%	438
2014 Q1	$137K	Sell	900 -15	-2%	-$2.38K	0.01%	447
2013 Q4	$122K	Sell	915 -118	-11%	-$14.2K	0.01%	461
2013 Q3	$120K	Hold	1,033	–	–	0.01%	447
2013 Q2	$95K	Buy	+1,033	New	+$99.5K	0.01%	459

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boston Private Bank & Trust's ALXN Position: Q1 2015 in Review

Boston Private Bank & Trust held its Alexion Pharmaceuticals (ALXN) position steady in Q1 2015 at 1,088 shares worth $189K. The position accounts for 0.01% of the portfolio, ranked #401.

Boston Private Bank & Trust first reported a position in ALXN in Q2 2013 and has held it in 8 quarters since. The position peaked at $201K in Q4 2014. 566 funds tracked by Wall St. Rank hold ALXN as of Q1 2015.

Boston Private Bank & Trust held 1,088 shares of Alexion Pharmaceuticals worth $189K as of Q1 2015.
Boston Private Bank & Trust left its Alexion Pharmaceuticals share count unchanged in Q1 2015.
Alexion Pharmaceuticals made up 0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #401 holding.
Boston Private Bank & Trust first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Alexion Pharmaceuticals position peaked at $201K in Q4 2014.
566 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.